Advanced Materials,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Aug. 21, 2024
Abstract
Addressing
osteoporosis‐related
bone
defects,
a
supramolecular
strategy
is
innovated
for
modifying
carbon
fiber
reinforced
polyether
ether
ketone
(CF/PEEK)
composites.
By
covalently
attaching
intelligent
macromolecules
via
in
situ
RAFT
polymerization,
leveraging
the
unique
pathological
microenvironment
patients
with
iron‐overloaded
osteoporosis,
modified
implant
surface
possesses
multiple
endogenous
modulation
capabilities.
After
implantation,
brush‐like
initially
resist
macrophage
adhesion,
thereby
reducing
level
of
immune
inflammation.
Over
time,
molecular
chains
undergo
conformational
changes
due
to
Fe
(III)
mediated
self‐assembly,
transforming
into
mechanistic
signals.
These
signals
are
then
specifically
transmitted
pre‐osteoblast
cell
through
binding
capacity
KRSR
short
peptide
at
terminus,
induced
their
osteogenic
differentiation
YAP/β‐catenin
signaling
axis.
Furthermore,
osteoblasts
secrete
alkaline
phosphatase
(ALP),
which
significantly
hydrolyzes
phosphate
ester
bonds
macromolecular
side
groups,
resulting
release
alendronate
(ALN).
This
process
further
improves
local
osteoporotic
microenvironment.
modification
tailors
repair
individual
conditions,
automatically
realize
regulation
once
implanted,
and
truly
spontaneous
activation
series
responses
conducive
vivo.
It
evidenced
by
improved
regeneration
rabbits
supported
vitro
validations.
Aggregate,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 2, 2024
ABSTRACT
Contagious
diseases
caused
by
different
types
of
highly
contagious
pathogens,
such
as
SARS‐CoV‐2,
monkeypox
virus,
Mycobacterium
tuberculosis
,
and
human
immunodeficiency
could
trigger
global
outbreaks
bring
a
huge
public
health
burden.
Advanced
diagnostic,
therapeutic,
preventive
strategies
are
urgently
needed
to
deal
with
the
epidemic
diseases.
Aggregation‐induced
emission
(AIE)
has
emerged
one
promising
candidates
that
exhibit
tunable
photophysical
properties,
high
biocompatibility,
exceptional
photostability,
distinguishing
aggregation‐enhanced
fluorescence.
As
result,
they
offer
effective
for
diagnosis,
treatment,
prevention
This
review
systematically
outlined
latest
research
progress
AIE‐based
biomaterials
mechanisms
in
The
versatility
AIE
molecules,
well
efficient
fluorescence
potential
innovative
combat
these
challenges.
Thanks
recent
advances
materials
science
better
understanding
aggregation‐induced
luminogens
(AIEgens),
AIEgens
have
great
provide
solutions
detection,
By
reviewing
state‐of‐the‐art
methods
killing,
agents
highlighting
technological
developments,
this
outlook
aims
promote
development
new
means
control
emerging,
re‐emerging,
major
further
activities
critical
area
research.
Burns & Trauma,
Journal Year:
2024,
Volume and Issue:
12
Published: Jan. 1, 2024
Abstract
Critical-sized
bone
defects
represent
a
significant
clinical
challenge
due
to
their
inability
undergo
spontaneous
regeneration,
necessitating
graft
interventions
for
effective
treatment.
The
development
of
tissue-engineered
scaffolds
and
regenerative
medicine
has
made
tissue
engineering
highly
viable
treatment
defects.
physical
biological
properties
nanocomposite
biomaterials,
which
have
optimized
structures
the
ability
simulate
microenvironment
bone,
are
promising
application
in
field
engineering.
These
biomaterials
offer
distinct
advantages
over
traditional
materials
by
facilitating
cellular
adhesion
proliferation,
maintaining
excellent
osteoconductivity
biocompatibility,
enabling
precise
control
degradation
rates,
enhancing
mechanical
properties.
Importantly,
they
can
natural
structure
tissue,
including
specific
microenvironment,
is
crucial
promoting
repair
regeneration
This
manuscript
provides
comprehensive
review
recent
research
developments
applications
structure-optimized
microenvironment-inspired
focuses
on
these
summarizing
latest
progress
highlighting
challenges
future
perspectives
field.
Through
this
analysis,
paper
aims
underscore
potential
engineering,
contributing
informed
design
strategic
planning
next-generation
medicine.
Advanced Healthcare Materials,
Journal Year:
2024,
Volume and Issue:
13(29)
Published: June 25, 2024
Emerging
infectious
diseases
like
coronavirus
pneumonia
(COVID-19)
present
significant
challenges
to
global
health,
extensively
affecting
both
human
society
and
the
economy.
Extracellular
vesicles
(EVs)
have
demonstrated
remarkable
potential
as
crucial
biomedical
tools
for
COVID-19
diagnosis
treatment.
However,
due
limitations
in
performance
titer
of
natural
vesicles,
their
clinical
use
remains
limited.
Nonetheless,
EV-inspired
strategies
are
gaining
increasing
attention.
Notably,
biomimetic
inspired
by
EVs,
possess
specific
receptors
that
can
act
"Trojan
horses,"
preventing
virus
from
infecting
host
cells.
Genetic
engineering
enhance
these
enabling
them
carry
more
receptors,
significantly
specificity
absorbing
novel
coronavirus.
Additionally,
inherit
numerous
cytokine
parent
cells,
allowing
effectively
mitigate
"cytokine
storm"
adsorbing
pro-inflammatory
cytokines.
Overall,
this
strategy
offers
new
avenues
treatment
emerging
diseases.
Herein,
review
systematically
summarizes
current
applications
COVID-19.
The
status
associated
with
implementation
also
discussed.
goal
is
provide
insights
into
design
expand
application
combating
Advanced Functional Materials,
Journal Year:
2024,
Volume and Issue:
34(44)
Published: May 23, 2024
Abstract
Current
treatment
of
postmenopausal
osteoporosis
(PMOP)
focuses
on
systemic
administration
medication,
neglecting
to
proactively
modulate
the
local
microenvironment
skeletal
system
for
superior
therapeutic
performance.
Eldecalcitol
(ED‐71),
a
novel
drug
treating
osteoporosis,
still
requires
research
overcome
high‐frequency
delivery
and
low‐utilization.
Here,
bone‐targeting
multishelled
nanoparticles
are
developed
step‐wise
release
ED‐71.
The
achieved
by
using
chitosan/alginate
outer
layer
as
protective
barrier
against
gastric
acid,
pectin
middle
adhesive
agent
that
improved
intestinal
penetration,
ethylene
diamine
tetraacetic
acid‐grafted
mesoporous
silica
nanomaterials
core
nanocarriers.
After
oral
administration,
ED‐71‐loaded
(ME‐ED‐71@PCA)
promotes
osteogenic
differentiation
bone
marrow
mesenchymal
stem
cells
reducing
intracellular
oxidative
stress,
inhibits
osteoclast
differentiation.
ME‐ED‐71@PCA
improves
mass
in
ovariectomized‐mice
promoting
osteogenesis
inhibiting
osteoclastogenesis,
efficacy
is
more
pronounced
than
ED‐71
alone.
exhibits
satisfactory
performance
due
its
compared
providing
new
approach
re‐establish
metabolic
homeostasis
PMOP.
Osteoporosis
is
a
systemic
metabolic
disease
that
impairs
bone
remodeling
by
favoring
osteoclastic
resorption
over
osteoblastic
formation.
Nanotechnology-based
therapeutic
strategies
focus
on
the
delivery
of
drug
molecules
to
either
decrease
or
increase
formation
rather
than
regulating
entire
process,
and
osteoporosis
interventions
suffer
from
this
limitation.
Here,
we
present
multifunctional
nanoparticle
based
metal-phenolic
networks
(MPNs)
for
treatment
both
osteoclasts
osteoblasts.
In
osteoporotic
microenvironment,
MPN
nanoparticles
degrade
trigger
release
bioactive
metals
(strontium
ions,
SrII)
promote
osteogenesis
functionalized
phenols
(epigallocatechin
gallate,
EGCG)
suppress
osteoclastogenesis.
Injecting
these
into
tail
vein
an
ovariectomized
mouse
model,
trabecular
loss
has
been
significantly
prevented
in
femoral
head
vertebrae,
along
with
increased
volume
decreased
separation.
Overall,
work
represents
versatile
approach
explore
nanomaterials
related
orthopedic
diseases.